Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02771197
Title Lymphodepletion and Anti-PD-1 Blockade to Reduce Relapse in AML Patient Not Eligible for Transplant
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Northside Hospital, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Blood and Marrow Transplant Group of Georgia Atlanta Georgia 30342 United States Details
Northside Hospital Atlanta Georgia 30342 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field